Description: Awakn Life Sciences Corp., a biotechnology company, develops and delivers psychedelic medicines to treat addiction and other mental health conditions in the United Kingdom and Europe. The company is headquartered in Toronto, Canada.
Home Page: awaknlifesciences.com
301-217 Queen Street West
Toronto,
ON
M5V 0R2
Canada
Phone:
Officers
| Name | Title |
|---|---|
| Mr. Anthony Tennyson | Co-founder, Pres, CEO & Director |
| Dr. Benjamin Sessa B.Sc., MBBS | Co-Founder, Head of Psychedelic Medicine & Member of Clinical Advisory Board |
| Mr. James Collins | Chief Operating Officer |
| Dr. Shaun McNulty Ph.D. | Chief Scientific Officer & Member of Pre-Clinical Advisory Board |
| Mr. George Scorsis | Co-founder & Chairman |
| Mr. Jonathan James Held C.A., CPA, CA | Co-Founder & CFO |
| Mr. Gordo Whittaker | Chief Marketing Officer |
| Prof. David John Nutt DM, FMedSci, FRCP, FRCPsych, FSB, Ph.D. | Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer |
| Prof. Celia Morgan | Head of Ketamine-Assisted Therapy & Member of Clinical Advisory Board |
| Dr. Lowan H. Stewart F.A.C.E.P., M.D. | Regional Director of Nordics & MD of Awakn Oslo AS |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.1918 |
| Price-to-Sales TTM: | 7.96 |
| IPO Date: | |
| Fiscal Year End: | January |
| Full Time Employees: | 43 |